{"entity":{"type":"insider","cik":"0001542073","url":"/insider/0001542073","json_url":"/insider/0001542073.json","name":"He Wei-Wu","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":20,"first":"2012-05-03","last":"2022-06-17","span_basis":"filed_date"},"name_variants":[{"name":"He Wei-Wu","source":"filing","n_filings":20,"first_seen":"2012-05-03","last_seen":"2022-06-17"}],"transactions":[{"id":6680467,"accession":"0001104659-22-072392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-072392","line_url":"/filing/0001104659-22-072392#line-3","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":159000.0,"total_display":"159,000.00","total_whole":"159,000","shares_owned_after":644553.0,"shares_owned_after_display":"644,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-17","scope":"insider"},{"id":6680464,"accession":"0001104659-22-072392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-072392","line_url":"/filing/0001104659-22-072392#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2096.0,"shares_display":"2,096","price_per_share":3.06,"price_display":"3.06","price_state":"stated","total_value":6413.76,"total_display":"6,413.76","total_whole":"6,414","shares_owned_after":594553.0,"shares_owned_after_display":"594,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-17","scope":"insider"},{"id":6680460,"accession":"0001104659-22-072392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-072392","line_url":"/filing/0001104659-22-072392#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36058.0,"shares_display":"36,058","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":107092.26,"total_display":"107,092.26","total_whole":"107,092","shares_owned_after":592457.0,"shares_owned_after_display":"592,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-17","scope":"insider"},{"id":5207048,"accession":"0001104659-21-141867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-141867","line_url":"/filing/0001104659-21-141867#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":196000.0,"total_display":"196,000.00","total_whole":"196,000","shares_owned_after":5558472.0,"shares_owned_after_display":"5,558,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider"},{"id":5207043,"accession":"0001104659-21-141867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-141867","line_url":"/filing/0001104659-21-141867#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":198000.0,"total_display":"198,000.00","total_whole":"198,000","shares_owned_after":5362569.0,"shares_owned_after_display":"5,362,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider"},{"id":4987759,"accession":"0001104659-21-108182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-108182","line_url":"/filing/0001104659-21-108182#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":180000.0,"shares_display":"180,000","price_per_share":1.26,"price_display":"1.26","price_state":"stated","total_value":226800.0,"total_display":"226,800.00","total_whole":"226,800","shares_owned_after":5163994.0,"shares_owned_after_display":"5,163,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider"},{"id":4987748,"accession":"0001104659-21-108182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-108182","line_url":"/filing/0001104659-21-108182#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":387000.0,"total_display":"387,000.00","total_whole":"387,000","shares_owned_after":4983994.0,"shares_owned_after_display":"4,983,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-20","scope":"insider"},{"id":4616492,"accession":"0001104659-21-043957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-043957","line_url":"/filing/0001104659-21-043957#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000000.0,"shares_display":"3,000,000","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":6150000.0,"total_display":"6,150,000.00","total_whole":"6,150,000","shares_owned_after":3000000.0,"shares_owned_after_display":"3,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-30","scope":"insider"},{"id":3177048,"accession":"0001104659-20-129106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-129106","line_url":"/filing/0001104659-20-129106#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":218000.0,"total_display":"218,000.00","total_whole":"218,000","shares_owned_after":5063994.0,"shares_owned_after_display":"5,063,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-24","scope":"insider"},{"id":3177038,"accession":"0001104659-20-129106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-129106","line_url":"/filing/0001104659-20-129106#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":127471.0,"shares_display":"127,471","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":270238.52,"total_display":"270,238.52","total_whole":"270,239","shares_owned_after":4963994.0,"shares_owned_after_display":"4,963,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-20","filed_date":"2020-11-24","scope":"insider"},{"id":3212841,"accession":"0001104659-20-086415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-086415","line_url":"/filing/0001104659-20-086415","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4152426.0,"shares_display":"4,152,426","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":7889609.4,"total_display":"7,889,609.40","total_whole":"7,889,609","shares_owned_after":4836523.0,"shares_owned_after_display":"4,836,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-24","scope":"insider","n_lines":2},{"id":2743228,"accession":"0001104659-20-064841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-064841","line_url":"/filing/0001104659-20-064841#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56464.0,"shares_display":"56,464","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":133819.68,"total_display":"133,819.68","total_whole":"133,820","shares_owned_after":1884097.0,"shares_owned_after_display":"1,884,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-21","scope":"insider"},{"id":2743220,"accession":"0001104659-20-064841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-064841","line_url":"/filing/0001104659-20-064841#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29801.0,"shares_display":"29,801","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":60496.03,"total_display":"60,496.03","total_whole":"60,496","shares_owned_after":1827663.0,"shares_owned_after_display":"1,827,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider"},{"id":2297707,"accession":"0001104659-20-063872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-063872","line_url":"/filing/0001104659-20-063872#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":338932.0,"shares_display":"338,932","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":684642.64,"total_display":"684,642.64","total_whole":"684,643","shares_owned_after":1797832.0,"shares_owned_after_display":"1,797,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-19","scope":"insider"},{"id":2297702,"accession":"0001104659-20-063872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-063872","line_url":"/filing/0001104659-20-063872#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":182000.0,"total_display":"182,000.00","total_whole":"182,000","shares_owned_after":1458900.0,"shares_owned_after_display":"1,458,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider"},{"id":3328436,"accession":"0001104659-20-040338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-040338","line_url":"/filing/0001104659-20-040338#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6880.0,"shares_display":"6,880","price_per_share":2.08,"price_display":"2.08","price_state":"stated","total_value":14310.4,"total_display":"14,310.40","total_whole":"14,310","shares_owned_after":1358900.0,"shares_owned_after_display":"1,358,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-27","filed_date":"2020-03-30","scope":"insider"},{"id":3130173,"accession":"0001104659-20-039667","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-039667","line_url":"/filing/0001104659-20-039667#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":328095.0,"shares_display":"328,095","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":685718.55,"total_display":"685,718.55","total_whole":"685,719","shares_owned_after":1352020.0,"shares_owned_after_display":"1,352,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-27","scope":"insider"},{"id":3130166,"accession":"0001104659-20-039667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-039667","line_url":"/filing/0001104659-20-039667#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":196398.0,"shares_display":"196,398","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":381012.12,"total_display":"381,012.12","total_whole":"381,012","shares_owned_after":1023925.0,"shares_owned_after_display":"1,023,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-27","scope":"insider"},{"id":3212383,"accession":"0001104659-20-036022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-036022","line_url":"/filing/0001104659-20-036022#line-3","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":234488.0,"shares_display":"234,488","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":368146.16,"total_display":"368,146.16","total_whole":"368,146","shares_owned_after":6332347.0,"shares_owned_after_display":"6,332,347","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-19","scope":"insider"},{"id":3212380,"accession":"0001104659-20-036022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-036022","line_url":"/filing/0001104659-20-036022#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":501322.0,"shares_display":"501,322","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":762009.44,"total_display":"762,009.44","total_whole":"762,009","shares_owned_after":6097859.0,"shares_owned_after_display":"6,097,859","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-19","scope":"insider"},{"id":3212376,"accession":"0001104659-20-036022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-036022","line_url":"/filing/0001104659-20-036022#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":264192.0,"shares_display":"264,192","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":396288.0,"total_display":"396,288.00","total_whole":"396,288","shares_owned_after":5596537.0,"shares_owned_after_display":"5,596,537","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":7974649,"accession":"0001144204-19-040830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-040830","line_url":"/filing/0001144204-19-040830#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":64000.0,"total_display":"64,000.00","total_whole":"64,000","shares_owned_after":827527.0,"shares_owned_after_display":"827,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-20","scope":"insider"},{"id":8709874,"accession":"0001144204-19-040279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-040279","line_url":"/filing/0001144204-19-040279#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160000.0,"shares_display":"160,000","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":507200.0,"total_display":"507,200.00","total_whole":"507,200","shares_owned_after":807527.0,"shares_owned_after_display":"807,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-15","scope":"insider"},{"id":6251398,"accession":"0001144204-18-016226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-016226","line_url":"/filing/0001144204-18-016226#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3086419.0,"shares_display":"3,086,419","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":9999997.56,"total_display":"9,999,997.56","total_whole":"9,999,998","shares_owned_after":4958024.0,"shares_owned_after_display":"4,958,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":5330859,"accession":"0001144204-17-052056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-052056","line_url":"/filing/0001144204-17-052056#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.95,"price_display":"1.95","price_state":"stated","total_value":195000.0,"total_display":"195,000.00","total_whole":"195,000","shares_owned_after":847527.0,"shares_owned_after_display":"847,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-11","scope":"insider"},{"id":4754176,"accession":"0001144204-17-051905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-051905","line_url":"/filing/0001144204-17-051905#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":186000.0,"total_display":"186,000.00","total_whole":"186,000","shares_owned_after":747527.0,"shares_owned_after_display":"747,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4754172,"accession":"0001144204-17-051905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-051905","line_url":"/filing/0001144204-17-051905#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":647527.0,"shares_owned_after_display":"647,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-10","scope":"insider"},{"id":4789476,"accession":"0001144204-17-048904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-048904","line_url":"/filing/0001144204-17-048904#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34002.0,"shares_display":"34,002","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":60523.56,"total_display":"60,523.56","total_whole":"60,524","shares_owned_after":547527.0,"shares_owned_after_display":"547,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-19","filed_date":"2017-09-20","scope":"insider"},{"id":4789472,"accession":"0001144204-17-048904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-048904","line_url":"/filing/0001144204-17-048904#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":173500.0,"shares_display":"173,500","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":303625.0,"total_display":"303,625.00","total_whole":"303,625","shares_owned_after":513525.0,"shares_owned_after_display":"513,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-18","filed_date":"2017-09-20","scope":"insider"},{"id":4535899,"accession":"0001144204-17-048556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-048556","line_url":"/filing/0001144204-17-048556#line-2","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":127702.0,"shares_display":"127,702","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":190275.98,"total_display":"190,275.98","total_whole":"190,276","shares_owned_after":340025.0,"shares_owned_after_display":"340,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-18","scope":"insider"},{"id":4535896,"accession":"0001144204-17-048556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-048556","line_url":"/filing/0001144204-17-048556#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187625.0,"shares_display":"187,625","price_per_share":1.22,"price_display":"1.22","price_state":"stated","total_value":228902.5,"total_display":"228,902.50","total_whole":"228,903","shares_owned_after":212323.0,"shares_owned_after_display":"212,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider"},{"id":3093871,"accession":"0001144204-16-127052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-127052","line_url":"/filing/0001144204-16-127052#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"CASI Pharmaceuticals, Inc.","issuer_ticker":"CASI","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1871605.0,"shares_display":"1,871,605","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":2227209.95,"total_display":"2,227,209.95","total_whole":"2,227,210","shares_owned_after":1871605.0,"shares_owned_after_display":"1,871,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":3012515,"accession":"0001144204-12-026006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-026006","line_url":"/filing/0001144204-12-026006#line-1","is_derivative":false,"issuer_cik":"0000895051","issuer_name":"ENTREMED INC","issuer_ticker":"ENMD","issuer_name_source":null,"issuer_url":"/issuer/0000895051","owner_cik":"0001542073","owner_name":"He Wei-Wu","owner_display_name":"He Wei-Wu","owner_url":"/insider/0001542073","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":441072.0,"shares_display":"441,072","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":441072.0,"shares_owned_after_display":"441,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-01","filed_date":"2012-05-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":34,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000895051","name":"CASI Pharmaceuticals, Inc.","url":"/issuer/0000895051","role":"Director, Officer (Chairman and CEO), Ten percent owner","n_filings":20,"first_seen":"2012-05-03","last_seen":"2022-06-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001542073","retrieved_at":"2026-08-24T12:42:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}